Study of rhASB in Patients With Mucopolysaccharidosis VI

Clinical trial NCT00104234 · COMPLETED

Trial details

NCT number: NCT00104234
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mucopolysaccharidosis VI

Start date: 2004-02-01
Primary completion: 2006-10-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.